药物发现的新方法 872条(本栏目收费,不能显示细节,电话15274084725)
Thiolactone containing molecules, 164 164
Thrombotic diseases, 230 230
Time-resolved fluorescence resonance energy 0
transfer (TR-FRET), 184 184
TIV. See Target identification and validation (TIV) 3T3 neutral red uptake phototoxicity test (3T3 NRU-PT), 275 275
3T3 NRU-PT. See 3T3 neutral red uptake phototoxicity test (3T3 NRU-PT) Toxicogenomics, 277 277
TPA. See Trifluoperazine (TPA) 0
Transcription-mediated amplification (TMA™) technology, 296–297 297
Translatability, preclinical animal models,66–67 67
Translational research (TR) process, 208–209 209
TR-FRET. See Time-resolved fluorescence resonance energy transfer (TR-FRET) Trifluoperazine (TPA), 132, 133 133
Trypanocidal lead ML341, 113 113
Type 1 diabetics (T1DM), 321 321
Vector-based stem-loop shRNAs, 29 29
WDI. See World Drug Index (WDI) 0
World Drug Index (WDI), 143 143
X-ray crystallography, 109 109